Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Iu Belousov

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Kardiologiia|December 13, 2003
[Results of pharmacoepidemiological study of arterial hypertension in Russia (PIFAGOR)]M V Leonova, D Iu Belousov
Kardiologiia|December 17, 2008
[Economics of nephroprotection in arterial hypertension and type 2 diabetes mellitus]Iu B Belousov, M V Shestakova, D Iu Belousov
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 24, 2004
[Cost-effect estimation of dopamine agonist (mirapex) application in patients with Parkinson's disease]A B Gekht, Iu B Belousov, E S Chikina, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Kardiologiia|December 13, 2003
[Results of pharmacoepidemiological study of arterial hypertension in Russia (PIFAGOR)]M V Leonova, D Iu Belousov
Kardiologiia|December 17, 2008
[Economics of nephroprotection in arterial hypertension and type 2 diabetes mellitus]Iu B Belousov, M V Shestakova, D Iu Belousov
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 24, 2004
[Cost-effect estimation of dopamine agonist (mirapex) application in patients with Parkinson's disease]A B Gekht, Iu B Belousov, E S Chikina, et al.
Pageof 1